Lifestance Health Group Inc (LFST) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lifestance Health Group Inc   (NASDAQ: LFST)


Lifestance Health Group Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lifestance Health Group Inc's ROI in the second quarter of 2026?
Lifestance Health Group Inc achieved a return on average invested assets (ROI) of 2.63 % in its second quarter of 2026, this is above LFST's average return on investment of -6.5%.
Lifestance Health Group Inc invested over the 12 months ending in its second quarter of 2026 $1,921 million

ROI has improved compared to 1.21% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 157 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1978 to 2291.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 1.37 % 1.51 % 1.37 % 0.31 % -0.66 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,907 1,906 1,952 1,920 1,905
Return On Investment (TTM) 2.63 % 1.21 % 0.5 % -0.48 % -0.5 %
LFST's Overall Ranking # 2291 # 1978 # 1966 # 2407 # 2127
Seq. Investment Change TTM 0.03 % 0.12 % 0.82 % 0.4 % 0.17 %
Seq. Net Income Change TTM 118.13 % 140.06 % - - -
Net Income (TTM) in Millions 51 23 10 -9 -9

LFST Company Profile >> Back to LFST Roi Comparisons >> See Annual LFST Return On Investment



Return On Investment LFST's Ranking
Within: No.
Industry # 52
Sector # 158
Overall # 2291

Return On Investment Statistics
High Average Low
2.61 %
-6.5 %
-19.67 %
(Jun 30 2026)   (Jun 30 2022)







Financial Statements
Lifestance Health Group Inc's II. Quarter Investments $ 1,907 Millions LFST's Balance sheet
Lifestance Health Group Inc's II. Quarter Income $ 24 Millions Quarterly LFST's Income Statement
LFST's Income by Division See LFST's Income by Division


LFST Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,952 1,889 1,907 1,998 1,756
Y / Y Investment Growth 3.31 % -0.93 % -4.54 % 13.77 % -
Net Income in Millions 10 -57 -186 -216 -307
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.5 % -3.04 % -9.77 % -10.79 % -17.49 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 0.5 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LFST's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LFST's Competitors
Subscribers only: Roi for Lifestance Health Group Inc's Suppliers
Subscribers only: Return On Investment for LFST's Customers

Other Ratios
LFST's Roa LFST's Inventory Turnover Ratio LFST's Growth Rates LFST's Dividend Statistics
LFST's Profitability Ratios LFST's Asset Turnover Ratio LFST's Dividend Growth
LFST's Roe LFST's Valuation Ratios LFST's Financial Strength Ratios LFST's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Davita Inc   6.92 %
Kewaunee Scientific Corporation  6.58 %
Medtronic Plc  6.46 %
Siga Technologies Inc  6.45 %
Labcorp Holdings Inc   6.11 %
Royalty Pharma Plc  6.09 %
Pacs Group Inc   5.86 %
Merit Medical Systems Inc  5.80 %
Ensign Group Inc  5.75 %
Nrc Health  5.72 %
IMPACT BIOMEDICAL INC.  5.68 %
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %

Date modified: 2026-09-12T06:25:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.